CompoAtlas

YouBest Prostate Support Pygeum Men's Formula

Natural health product licensed in Canada

Other names
Daily Care Prostate Support Pygeum with Lycopene, Prostate Support Pygeum Men's Formula, Prostate Support Pygeum with Lycopene
Licence holder
Cancap Pharmaceutical Ltd.
NPN or DIN-HM
80081978
Status
Inactive licence
Licence date
20 December 2017
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Serenoa repens

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1 Grammes

Potency : 85 % Fatty acids

100 milligrammeNot calculated
Lycopène

Source : Lycopène

10 milligrammeNot calculated
Prunus africana

Source : Écorce (tige)

Extract : Matériel brut sec

Extraction ratio : 200:1

Dry plant equivalent : 10 Grammes

Potency : 13 % beta-Sitosterol

50 milligrammeNot calculated
Prunus africana

Source : Ecorce (tronc)

Extract : Matériel brut sec

Extraction ratio : 200:1

Dry plant equivalent : 10 Grammes

Potency : 13 % beta-Sitosterol

50 milligrammeNot calculated
Prunus africana

Source : Écorce âgée

Extract : Matériel brut sec

Extraction ratio : 200:1

Dry plant equivalent : 10 Grammes

Potency : 13 % beta-Sitosterol

50 milligrammeNot calculated

Non-medicinal ingredients

Gélatine, Eau purifiée, Huile de graine de citrouille, Caramel, Cire d'abeille, Glycérine, Lécithine

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinNot specified1 Capsule2 Tous les jours

Uses authorised in Canada

Helps to support prostate health. Helps reduce the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and nighttime urination) associated with benign prostatic hyperplasia.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80081978

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Serenoa repens
    Read the warning, when it applies and the studies cited

    SAW PALMETTO – SERENOA REPENS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All subpopulations.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Adult males only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Adult females only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Adult females only.

    Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Prunus africana
    Read the warning, when it applies and the studies cited

    PYGEUM - PRUNUS AFRICANA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Standardized extracts making a claim for symptoms of benign prostatic hyperplasia (adult males).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (Goldman and Ausiello 2004).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Non-standardized preparations for adults (i.e., including women) (safety only).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 26 June 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line